HEDRICK MARC H — SEC Form 4 Insider Trading Activity
Summary
Updated Jul 16, 2026
HEDRICK MARC H has filed 2 SEC Form 4 filings across 1 company in the last 90 days.
Profile
Marc H. Hedrick is the Chief Executive Officer of Plus Therapeutics, Inc., a clinical-stage pharmaceutical company focused on developing treatments for cancer and rare diseases. He has been involved in the biotechnology sector and has held various leadership roles in companies dedicated to innovative healthcare solutions.
Role
Insider
Notability
50/100
Board memberships
Plus Therapeutics, Inc.
Awards & honors
Leadership in clinical-stage pharmaceutical development
Marc H. Hedrick is the Chief Executive Officer of Plus Therapeutics, Inc., a clinical-stage pharmaceutical company focused on developing treatments for cancer and rare diseases. He has been involved in the biotechnology sector and has held various leadership roles in companies dedicated to innovative healthcare solutions.…
How many SEC Form 4 filings has HEDRICK MARC H submitted recently?
2 primary Form 4 filings in the last 90 days, covering 1 company.
Where can I see all of HEDRICK MARC H's SEC filings?
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
